Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    " July 17, 2011":" August 16, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
Condition: HIV-1 Infection
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: Tenofovir disoproxil fumarate;   Drug: Emtricitabine;   Drug: Placebo for Tenofovir disoproxil fumarate;   Drug: Placebo for Maraviroc;   Drug: Maraviroc
22 Active, not recruiting Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Conditions: Leukemia;   Lymphoma;   HIV
Interventions: Drug: Fludarabine and Busulfan;   Drug: Fludarabine and Melphalan;   Drug: Busulfan and Fludarabine;   Drug: Cyclophosphamide and Total Body Irradiation
23 Completed Novel Therapy for Glucose Intolerance in HIV Disease
Condition: Insulin Resistance
Intervention: Dietary Supplement: Chromium Picolinate
24 Completed HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth
Conditions: Acquired Immunodeficiency Syndrome;   Stress Disorders, Post-Traumatic
Intervention: Behavioral: Questionnaires
25 Completed Vitamin D and HIV-Cardiovascular Disease in Children and Young Adults
Condition: Vitamin D Deficiency
Intervention:
26 Recruiting Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Conditions: Liver Diseases, Alcoholic;   Alcoholism;   HIV;   Hepatitis C
Interventions: Other: Integrated Stepped Care (ISC);   Other: Treatment as Usual
27 Completed
Has Results
Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy
Conditions: HIV;   AIDS;   Peripheral Neuropathy;   Pain;   Sleep
Interventions: Device: Splinting application to the lower extremities;   Device: Splint liner application
28 Completed Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults
Condition: Hepatitis c
Intervention: Behavioral: Leap-c group intervention
29 Completed
Has Results
Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)
Condition: Hepatitis C, Chronic
Interventions: Drug: PegIFN/RBV;   Drug: BI201335;   Drug: BI201335 24W;   Drug: Bi 201335

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-29) Next Page   
Study has passed its completion date and status has not been verified in more than two years.